Angelita Rebamontan Domingo - 20 Dec 2021 Form 3 Insider Report for PRO DEX INC (PDEX)

Role
Director
Signature
/s/ Alisha Charlton, attorny-in-fact pursuant to power of attorney filed herewith
Issuer symbol
PDEX
Transactions as of
20 Dec 2021
Net transactions value
$0
Form type
3
Filing time
06 Jan 2022, 18:00:56 UTC
Next filing
31 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PDEX Common Stock 7,011 20 Dec 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PDEX Stock Option (Right to buy) 20 Dec 2021 Common Stock 4,250 $27.50 Direct F1
holding PDEX Stock Option (Right to buy) 20 Dec 2021 Common Stock 4,250 $39.00 Direct F1
holding PDEX Stock Option (Right to buy) 20 Dec 2021 Common Stock 4,250 $42.00 Direct F1
holding PDEX Stock Option (Right to buy) 20 Dec 2021 Common Stock 4,250 $47.50 Direct F1
holding PDEX Stock Option (Right to buy) 20 Dec 2021 Common Stock 4,250 $50.00 Direct F1
holding PDEX Performance Award 20 Dec 2021 Common Stock 5,800 $0.000000 Direct F2
holding PDEX Performance Award 20 Dec 2021 Common Stock 5,800 $0.000000 Direct F2
holding PDEX Performance Award 20 Dec 2021 Common Stock 5,800 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were awarded under Pro-Dex's 2016 Equity Incentive Plan. The percentage of options that may vest and become exercisable, if any, are 100%, 50%, and 25%, respectively, based upon the volume-weighted average price of Pro-Dex's common stock equaling or exceeding the applicable exercise price for the 60 trading days immediately preceding the date the option becomes exercisable, six months from the date the option becomes exercisable, or twelve months from the date the option becomes exercisable, respectively.
F2 These performance awards were awarded under Pro-Dex's 2016 Equity Incentive Plan. Shares of Pro-Dex common stock will be granted to the reporting person in the amounts shown above on the date exercisable shown above, as the vesting criteria for these performance awards have already been satisfied as of the date of this report.

Remarks:

EXHIBIT LIST: Exhibit 24 - Power of Attorney